4EBP1/eIF4E and p70S6K/RPS6 Axes Play Critical and Distinct Roles in Hepatocarcinogenesis Driven by AKT and N-Ras Proto-oncogenes in Mice

被引:77
作者
Wang, Chunmei [1 ]
Cigliano, Antonio [3 ]
Jiang, Lijie [1 ]
Li, Xiaolei [1 ,4 ]
Fan, Biao [1 ]
Pilo, Maria G. [3 ]
Liu, Yan [1 ]
Gui, Bing [1 ]
Sini, Marcella [3 ]
Smith, Jeffrey W. [5 ]
Dombrowski, Frank [3 ]
Calvisi, Diego F. [3 ]
Evert, Matthias [3 ]
Chen, Xin [1 ,2 ]
机构
[1] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA
[3] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Greifswald, Germany
[4] Fourth Mil Med Univ, Dept Hepatobiliary Surg, Xijing Hosp, Xian 710032, Peoples R China
[5] Sanford Burnham Med Res Inst, La Jolla, CA USA
关键词
RIBOSOMAL-PROTEIN S6; HEPATOCELLULAR-CARCINOMA; TRANSLATIONAL CONTROL; TARGETED THERAPIES; SIGNALING PATHWAYS; TUMOR-DEVELOPMENT; LIVER-CANCER; COMPLEX; MTOR; GROWTH;
D O I
10.1002/hep.27396
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Concomitant expression of activated forms of v-akt murine thymoma viral oncogene homolog (AKT) and Ras in mouse liver (AKT/Ras) leads to rapid tumor development through strong activation of the mammalian target of rapamycin complex 1 (mTORC1) pathway. mTORC1 functions by regulating p70S6K/ribosomal protein S6 (RPS6) and eukaryotic translation initiation factor 4E-binding protein 1/ eukaryotic translation initiation factor 4E (4EBP1/eIF4E) cascades. How these cascades contribute to hepatocarcinogenesis remains unknown. Here, we show that inhibition of the RPS6 pathway by rapamycin effectively suppressed, whereas blockade of the 4EBP1/eIF4E cascade by 4EBP1A4, an unphosphorylatable form of 4EBP1, significantly delayed, AKT/Ras-induced hepatocarcinogenesis. Combined treatment with rapamycin and 4EBP1A4 completely inhibited AKT/Ras hepatocarcinogenesis. This strong antineoplastic effect was successfully recapitulated by ablating regulatory associated protein of mTORC1, the major subunit of mTORC1, in AKT/Ras-overexpressing livers. Furthermore, we demonstrate that overexpression of eIF4E, the proto-oncogene whose activity is specifically inhibited by 4EBP1, resulted in hepatocellular carcinoma (HCC) development in cooperation with activated Ras. Mechanistically, we identified the ectonucleoside triphosphate diphosphohydrolase 5/ adenylate kinase 1/cytidine monophosphate kinase 1 axis and the mitochondrial biogenesis pathway as targets of the 4EBP1/eIF4E cascade in AKT/Ras and Ras/eIF4E livers as well as in human HCC cell lines and tissues. Conclusions: Complete inhibition of mTORC1 is required to suppress liver cancer development induced by AKT and Ras proto-oncogenes in mice. The mTORC1 effectors, RPS6 and eIF4E, play distinct roles and are both necessary for AKT/Ras hepatocarcinogenesis. These new findings might open the way for innovative therapies against human HCC. (Hepatology 2015;61:200-213)
引用
收藏
页码:200 / 213
页数:14
相关论文
共 44 条
[1]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[2]   Management of Hepatocellular Carcinoma: An Update [J].
Bruix, Jordi ;
Sherman, Morris .
HEPATOLOGY, 2011, 53 (03) :1020-1022
[3]   Rapamycin Delays Tumor Development in Murine Livers by Inhibiting Proliferation of Hepatocytes with DNA Damage [J].
Buitrago-Molina, Laura Elisa ;
Pothiraju, Deepika ;
Lamle, Jutta ;
Marhenke, Silke ;
Kossatz, Uta ;
Breuhahn, Kai ;
Manns, Michael P. ;
Malek, Nisar ;
Vogel, Arndt .
HEPATOLOGY, 2009, 50 (02) :500-509
[4]   Ubiquitous activation of Ras and Jak/Stat pathways in human HCC [J].
Calvisi, DF ;
Ladu, S ;
Gorden, A ;
Farina, M ;
Conner, EA ;
Lee, JS ;
Factor, VM ;
Thorgeirsson, SS .
GASTROENTEROLOGY, 2006, 130 (04) :1117-1128
[5]   Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma [J].
Calvisi, Diego F. ;
Wang, Chunmei ;
Ho, Coral ;
Ladu, Sara ;
Lee, Susie A. ;
Mattu, Sandra ;
Destefanis, Giulia ;
Delogu, Salvatore ;
Zimmermann, Antje ;
Ericsson, Johan ;
Brozzetti, Stefania ;
Staniscia, Tommaso ;
Chen, Xin ;
Dombrowski, Frank ;
Evert, Matthias .
GASTROENTEROLOGY, 2011, 140 (03) :1071-U542
[6]   Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse [J].
Carlson, CM ;
Frandsen, JL ;
Kirchhof, N ;
McIvor, RS ;
Largaespada, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (47) :17059-17064
[7]   The Oncogene eIF4E: Using Biochemical Insights to Target Cancer [J].
Carroll, Martin ;
Borden, Katherine L. B. .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2013, 33 (05) :227-238
[8]   Blocking eIF4E-eIF4G Interaction as a Strategy To Impair Coronavirus Replication [J].
Cencic, Regina ;
Desforges, Marc ;
Hall, David R. ;
Kozakov, Dima ;
Du, Yuhong ;
Min, Jaeki ;
Dingledine, Raymond ;
Fu, Haian ;
Vajda, Sandor ;
Talbot, Pierre J. ;
Pelletier, Jerry .
JOURNAL OF VIROLOGY, 2011, 85 (13) :6381-6389
[9]   Hydrodynamic Transfection for Generation of Novel Mouse Models for Liver Cancer Research [J].
Chen, Xin ;
Calvisi, Diego F. .
AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (04) :912-923
[10]   Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation [J].
Choo, Andrew Y. ;
Yoon, Sang-Oh ;
Kim, Sang Gyun ;
Roux, Philippe P. ;
Blenis, John .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (45) :17414-17419